CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nissui Pharmaceutical CO., LTD. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nissui Pharmaceutical CO., LTD.
20F, Ueno Frontier Tower, 3-24-6, Ueno
Phone: +81 358465611p:+81 358465611 Taito-Ku, TKY  110-8736  Japan Fax: +81 358465619f:+81 358465619
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Nissui Pharmaceutical Co.,Ltd. is a Japan-based company mainly engaged in the manufacture, purchase and sale of clinical diagnostic drugs, industrial diagnostic drugs, pharmaceuticals, among others. The Company operates through two business segments. The Diagnostic Drug segment is involved in the manufacture, purchase and sale of culture media, clinical diagnostic drugs, industrial diagnostic drugs and raw materials for medical institutions, research institutions and industrial facilities, as well as the purchase and sale of testing equipment and other equipment. The Pharmaceutical segment is involved in the manufacture, purchase and sale of pharmaceuticals and health foods for pharmacies and drugstores. The Company’s main products include clinical diagnostic drugs, industrial diagnostic drugs such as compactdry, pharmaceuticals such as therapeutics, nourishing tonics and health foods.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20223/31/2022Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2834 Pharmaceutical preparations
5047 Medical, dental, and hospital equipment and supplies
4212 Local trucking without storage

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive President, Representative Director TokuyaOno 55 6/24/2014 6/24/2010
Executive Officer, Senior Director of Sales, Director of Overseas Sales, Director ShinSaito 59 4/1/2022 4/1/2013
Executive Officer, Chief Director of Industrial Reagent Sales, Director of CC Sales SeijiTanaka 4/1/2022
9 additional Officers and Directors records available in full report.

Business Names
Business Name
4550
LISBLANC Co.,Ltd
Nissui Pharmaceutical Co., Ltd.

General Information
Number of Employees: 239 (As of 3/31/2022)
Outstanding Shares: 9,841,153 (As of 9/30/2022)
Shareholders: 9,696
Stock Exchange: TYO
Fax Number: +81 358465619


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 15, 2024